Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA 98195, USA.
Liver Transpl. 2010 Nov;16(11):1296-302. doi: 10.1002/lt.22162.
Controversies exist with respect to the mortality of patients undergoing liver transplantation at the extremes of the body mass index (BMI). For pediatric liver transplantation, weight is usually the only factor considered in survival analysis. A review of the United Network for Organ Sharing database (1987-2007) revealed 9701 pediatric patients (<18 years old) who underwent primary liver transplantation. Patients were stratified into 5 BMI categories established by the World Health Organization according to their Z score, which was based on age, gender, and BMI: -3, -2, 0, +2, and +3. The survival rates in these 5 categories were compared with Kaplan-Meier survival curves and log-rank testing. Patients with thinness (Z score = -2) and severe thinness (Z score = -3) had significantly (P < 0.0001) lower survival at 1 year (84.4%) versus the survival (88.7%) of the normal and overweight groups (Z score = 0 and Z score = + 2, respectively). For patients with obesity (Z score = +3), there was no significant difference in survival early after transplantation, but their mortality gradually increased in the later years after transplantation. By 12 years after liver transplantation, the obese group had significantly (P = 0.04) lower survival (72%) than the normal and overweight groups (77%). In conclusion, liver transplantation holds increased risk for obese pediatric patients. Thin pediatric patients experience early mortality after liver transplantation, and obese pediatric patients experience late mortality after liver transplantation. Transplant management can be modified to optimize the care of these patients.
对于体质量指数(BMI)处于极值的肝移植患者的死亡率存在争议。对于儿科肝移植,生存分析中通常仅考虑体重。对 1987 年至 2007 年美国器官共享联合网络数据库的审查显示,有 9701 名儿科患者(<18 岁)接受了原发性肝移植。患者根据其 Z 分数分为 5 个 BMI 类别,由世界卫生组织根据年龄、性别和 BMI 建立:-3、-2、0、+2 和+3。对这些 5 个类别中的生存率进行了比较,采用 Kaplan-Meier 生存曲线和对数秩检验。消瘦(Z 分数=-2)和严重消瘦(Z 分数=-3)患者的 1 年生存率显著(P<0.0001)低于正常和超重组(Z 分数=0 和 Z 分数=+2)的生存率(分别为 88.7%和 84.4%)。对于肥胖(Z 分数=+3)患者,移植后早期生存率无显著差异,但在移植后数年死亡率逐渐增加。肝移植后 12 年,肥胖组的生存率显著(P=0.04)低于正常和超重组(分别为 72%和 77%)。总之,肥胖儿科患者肝移植的风险增加。消瘦的儿科患者在肝移植后早期死亡,肥胖的儿科患者在肝移植后晚期死亡。可以修改移植管理以优化对这些患者的治疗。